CY1108684T1 - Φαρμακευτικες συνθεσεις που περιλαμβανουν ασκορβικο οξυ για τη θεραπεια μυκητοειδων υπερμολυνσεων και μυκητοειδων επανεμφανισεων - Google Patents
Φαρμακευτικες συνθεσεις που περιλαμβανουν ασκορβικο οξυ για τη θεραπεια μυκητοειδων υπερμολυνσεων και μυκητοειδων επανεμφανισεωνInfo
- Publication number
- CY1108684T1 CY1108684T1 CY20081101515T CY081101515T CY1108684T1 CY 1108684 T1 CY1108684 T1 CY 1108684T1 CY 20081101515 T CY20081101515 T CY 20081101515T CY 081101515 T CY081101515 T CY 081101515T CY 1108684 T1 CY1108684 T1 CY 1108684T1
- Authority
- CY
- Cyprus
- Prior art keywords
- functional
- ascorbic acid
- compositions containing
- pharmaceutical compositions
- containing ascorbic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Η παρούσα εφεύρεση απευθύνεται σε συνθέσεις που περιέχουν ασκορβικό οξύ ή ένα φυσιολογικώς αποδεκτό άλας αυτού για την παρασκευή μιας φαρμακοτεχνικής μορφής χρήσιμης για την πρόληψη επανεμφανίσεων μυκητοειδών μολύνσεων ή μυκητοειδών υπερμολύνσεων σε ασθενείς που βρίσκονται σε κίνδυνο.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03077314A EP1500394A1 (en) | 2003-07-22 | 2003-07-22 | Pharmaceutical compositions comprising ascorbic acid or the treatment of fungal superinfections and fungal recurrences |
EP04739316A EP1646378B1 (en) | 2003-07-22 | 2004-05-21 | Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108684T1 true CY1108684T1 (el) | 2014-04-09 |
Family
ID=33483977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081101515T CY1108684T1 (el) | 2003-07-22 | 2008-12-31 | Φαρμακευτικες συνθεσεις που περιλαμβανουν ασκορβικο οξυ για τη θεραπεια μυκητοειδων υπερμολυνσεων και μυκητοειδων επανεμφανισεων |
Country Status (23)
Country | Link |
---|---|
US (1) | US7863326B2 (el) |
EP (2) | EP1500394A1 (el) |
JP (1) | JP4791358B2 (el) |
KR (1) | KR101100713B1 (el) |
CN (1) | CN100540000C (el) |
AR (1) | AR045070A1 (el) |
AT (1) | ATE413171T1 (el) |
BR (1) | BRPI0412453A (el) |
CA (1) | CA2528879A1 (el) |
CY (1) | CY1108684T1 (el) |
DE (1) | DE602004017613D1 (el) |
DK (1) | DK1646378T3 (el) |
EA (1) | EA010241B1 (el) |
ES (1) | ES2314406T3 (el) |
HK (1) | HK1092693A1 (el) |
HR (1) | HRP20090022T3 (el) |
MX (1) | MXPA05013798A (el) |
PL (1) | PL1646378T3 (el) |
PT (1) | PT1646378E (el) |
SI (1) | SI1646378T1 (el) |
UA (1) | UA88446C2 (el) |
WO (1) | WO2005013971A1 (el) |
ZA (1) | ZA200509851B (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007000662A2 (en) * | 2005-02-03 | 2007-01-04 | Taro Pharmaceuticals U.S.A., Inc. | Novel propofol composition comprising ascorbic acid or pharmaceutically acceptable salts thereof |
US20090197946A1 (en) * | 2008-01-31 | 2009-08-06 | Joseph Di Bartolomeo | Composition and method for treatment of inflamation and infections of the genitalia, contraceptive and the prophylaxis of sexually transmitted diseases |
FI20095550A0 (fi) * | 2009-05-19 | 2009-05-19 | Bayer Schering Pharma Oy | Vaginaalinen antojärjestelmä |
ES2477141B2 (es) * | 2010-04-08 | 2015-02-23 | University Of Florida Research Foundation, Inc. | Sistema basado en un vector viral de expresión transitoria que permite múltiples aplicaciones |
DE102012009057A1 (de) | 2012-05-09 | 2013-11-14 | Dr. Arabin GmbH & Co. KG | Rotationspessar mit zusätzlicher Wirkstoffkomponente |
FR3018193B1 (fr) | 2014-03-10 | 2017-09-08 | Probionov | Comprime vaginal muco-adhesif a liberation prolongee |
US11865139B2 (en) * | 2020-11-12 | 2024-01-09 | Thermolife International, Llc | Method of treating migraines and headaches |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4229430A (en) * | 1978-08-21 | 1980-10-21 | Fahim Mostafa S | Oral composition for improving oral health |
JPH01125306A (ja) * | 1987-11-09 | 1989-05-17 | Daiichi Seimo Kk | 赤腐れ菌の防除剤 |
DE59101214D1 (de) | 1991-07-15 | 1994-04-21 | Artesan Pharma Gmbh | Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich. |
US5425944A (en) * | 1992-10-27 | 1995-06-20 | Harich; Jakob | Antimicrobial grapefruit extract |
US6416779B1 (en) * | 1997-06-11 | 2002-07-09 | Umd, Inc. | Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
CN1245074A (zh) * | 1998-04-26 | 2000-02-23 | 曾忠铭 | 减弱阴道酸度的药剂和用途 |
US6153635A (en) * | 1998-11-20 | 2000-11-28 | Upmalis; David H. | Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate |
JP2000169370A (ja) * | 1998-12-09 | 2000-06-20 | Frontier:Kk | 肉食動物用皮膚疾患治療薬及び健康食品 |
DE29900513U1 (de) * | 1999-01-14 | 2000-08-10 | Rst Icking Gmbh | Schuh- bzw. Fuß-Hygienemittel |
RU2150935C1 (ru) * | 1999-06-22 | 2000-06-20 | Московский государственный медико-стоматологический университет | Защитно-профилактический крем |
US6391330B1 (en) * | 2000-05-11 | 2002-05-21 | Michael A. Ross | Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa |
US20030130225A1 (en) * | 2001-10-16 | 2003-07-10 | Nawaz Ahmad | Novel methods of treating local fungal and bacterial infections |
-
2003
- 2003-07-22 EP EP03077314A patent/EP1500394A1/en not_active Withdrawn
-
2004
- 2004-05-21 CN CNB2004800183098A patent/CN100540000C/zh not_active Expired - Fee Related
- 2004-05-21 DK DK04739316T patent/DK1646378T3/da active
- 2004-05-21 DE DE602004017613T patent/DE602004017613D1/de active Active
- 2004-05-21 MX MXPA05013798A patent/MXPA05013798A/es active IP Right Grant
- 2004-05-21 EP EP04739316A patent/EP1646378B1/en active Active
- 2004-05-21 SI SI200430949T patent/SI1646378T1/sl unknown
- 2004-05-21 BR BRPI0412453-7A patent/BRPI0412453A/pt not_active Application Discontinuation
- 2004-05-21 PL PL04739316T patent/PL1646378T3/pl unknown
- 2004-05-21 ES ES04739316T patent/ES2314406T3/es active Active
- 2004-05-21 CA CA002528879A patent/CA2528879A1/en not_active Withdrawn
- 2004-05-21 EA EA200600176A patent/EA010241B1/ru not_active IP Right Cessation
- 2004-05-21 UA UAA200600565A patent/UA88446C2/uk unknown
- 2004-05-21 JP JP2006520679A patent/JP4791358B2/ja not_active Expired - Fee Related
- 2004-05-21 ZA ZA200509851A patent/ZA200509851B/en unknown
- 2004-05-21 WO PCT/EP2004/005559 patent/WO2005013971A1/en active Application Filing
- 2004-05-21 AT AT04739316T patent/ATE413171T1/de active
- 2004-05-21 KR KR1020057024553A patent/KR101100713B1/ko not_active IP Right Cessation
- 2004-05-21 US US10/563,912 patent/US7863326B2/en active Active
- 2004-05-21 PT PT04739316T patent/PT1646378E/pt unknown
- 2004-07-21 AR ARP040102588A patent/AR045070A1/es unknown
-
2006
- 2006-09-22 HK HK06110599.8A patent/HK1092693A1/xx not_active IP Right Cessation
-
2008
- 2008-12-31 CY CY20081101515T patent/CY1108684T1/el unknown
-
2009
- 2009-01-16 HR HR20090022T patent/HRP20090022T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN1812781A (zh) | 2006-08-02 |
KR20060040603A (ko) | 2006-05-10 |
EP1646378A1 (en) | 2006-04-19 |
JP2006528138A (ja) | 2006-12-14 |
PL1646378T3 (pl) | 2009-04-30 |
MXPA05013798A (es) | 2006-06-27 |
DK1646378T3 (da) | 2009-01-19 |
US7863326B2 (en) | 2011-01-04 |
CA2528879A1 (en) | 2005-02-17 |
EP1646378B1 (en) | 2008-11-05 |
UA88446C2 (uk) | 2009-10-26 |
HRP20090022T3 (en) | 2009-02-28 |
CN100540000C (zh) | 2009-09-16 |
WO2005013971A1 (en) | 2005-02-17 |
DE602004017613D1 (de) | 2008-12-18 |
BRPI0412453A (pt) | 2006-10-17 |
AR045070A1 (es) | 2005-10-12 |
HK1092693A1 (en) | 2007-02-16 |
EP1500394A1 (en) | 2005-01-26 |
SI1646378T1 (sl) | 2009-02-28 |
ZA200509851B (en) | 2007-03-28 |
JP4791358B2 (ja) | 2011-10-12 |
EA200600176A1 (ru) | 2006-06-30 |
EA010241B1 (ru) | 2008-06-30 |
PT1646378E (pt) | 2008-12-17 |
ATE413171T1 (de) | 2008-11-15 |
KR101100713B1 (ko) | 2011-12-30 |
ES2314406T3 (es) | 2009-03-16 |
US20070037880A1 (en) | 2007-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108684T1 (el) | Φαρμακευτικες συνθεσεις που περιλαμβανουν ασκορβικο οξυ για τη θεραπεια μυκητοειδων υπερμολυνσεων και μυκητοειδων επανεμφανισεων | |
CY1118936T1 (el) | Φαρμακευτικες συνθεσεις και μεθοδοι για την αγωγη ή την προληψη νοσου σχετιζομενης με οξαλικο | |
CY1112376T1 (el) | Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2 | |
CY1105362T1 (el) | Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα | |
EA200700362A1 (ru) | Конъюгат, содержащий антивирусное соединение, в частности ингибирующее вич, фармацевтическая композиция и набор стандартной дозы лекарственного препарата на его основе, способ ингибирования с его помощью | |
CY1117656T1 (el) | Επιλογες θεραπειας για τη νοσο του fabry | |
CY1122349T1 (el) | Παραγωγα 1-benzyλ-3-υδροξυμεθυλινδαζολης και χρηση αυτων στη θεραπεια νοσων που βασιζονται στην εκφραση των mcp-1, cxcr1 και ρ40 | |
DE602004017194D1 (de) | Pyridylpyrrol-derivate als wirksame kinase-hemmer | |
CY1108992T1 (el) | Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας | |
CY1109843T1 (el) | Αναλογα της βιταμινης d | |
CY1111613T1 (el) | Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv | |
MD20070267A (en) | Gastroresistant pharmaceutical formulation containing rifaximin | |
CY1106386T1 (el) | Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης | |
CR8102A (es) | Derivados de pirazolo- quinazolina, procedimiento para preparacion y su uso como inhibidores de quinasa | |
NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
CY1110332T1 (el) | Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους | |
CY1115386T1 (el) | Συνδυασμος αζελαστινης και μομεταζονης | |
BR0113838A (pt) | Derivados de n-fenil-2-pirimidina-amina | |
BRPI0418251B8 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
ATE442142T1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
EA200602137A1 (ru) | Гидрогелевые препараты интерферона | |
NO20055891L (no) | Kinazolinderivater som aurorakinaseinhibitorer | |
CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
CY1113894T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει ροφλουμιλαστη και λεβοκετιριζινη |